Pricing

Thimble Point Acquisition Corp (THMAU)

followers ·
Sector: FINANCE
Industry: GENERAL FINANCE
CEO: Corey M. McCann
Employees: 300
Web site: peartherapeutics.com
200 STATE STREET, 13TH FLOOR, BOSTON, MA, 02109
6469322774

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

All 13F Filers Prior Change Hedge Funds 1 Prior Change
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available